Rodent and human mast cells produce functionally significant intracellular reactive oxygen species but not nitric oxide.
In immunity, reactive oxygen species (ROS) and nitric oxide (NO) are important antimicrobial agents and regulators of cell signaling and activation pathways. However, the cellular sources of ROS and NO are much debated. Particularly, there is contention over whether mast cells, key secretory cells in allergy and immunity, can generate these chemical species, and if so, whether they are of functional significance. We therefore examined directly by flow cytometry the capacity of mast cells to generate intracellular ROS and NO using the respective cell-permeable fluorescent probes dichlorodihydrofluorescein and diaminofluorescein and evaluated the effects of inhibitors of ROS and NO synthesis on cell degranulation. For each of three mast cell types (rat peritoneal mast cells, mouse bone marrow-derived mast cells, and human blood-derived mast cells), degranulation stimulated by IgE/antigen was accompanied by production of intracellular ROS but not NO. Inhibition of ROS production led to reduced degranulation, indicating a facilitatory role for ROS, whereas NO synthase inhibitors were without effect. Likewise, bacterial lipopolysaccharide and interferon-gamma over a wide range of conditions failed to generate intracellular NO in mast cells, whereas these agents readily induced intracellular NO in macrophages. NO synthase protein, as assessed by Western blotting, was readily induced in macrophages but not mast cells. We conclude that rodent and human mast cells generate intracellular ROS but not NO and that intracellular ROS but not intracellular NO are functionally linked to mast cell degranulation.
Swindle
Emily J
EJ
Department of Pharmacology, University of Liverpool, Liverpool L69 3GE, United Kingdom. ejswindle@naid.nih.gov
Metcalfe
Dean D
DD
Coleman
John W
JW
D000818:Animals; D000941:Antigens / Q000737:chemistry; D015153:Blotting, Western; D002478:Cells, Cultured; D005260:Female; D005434:Flow Cytometry; D019793:Fluorescein / Q000494:pharmacology; D005452:Fluoresceins / Q000494:pharmacology; D006801:Humans; D015151:Immunoblotting; D007073:Immunoglobulin E / Q000737:chemistry; D007202:Indicators and Reagents / Q000494:pharmacology; D007371:Interferon-gamma / Q000378:metabolism; D008070:Lipopolysaccharides / Q000737:chemistry; D008264:Macrophages / Q000378:metabolism; D008407:Mast Cells / Q000378:metabolism*; D051379:Mice; D009569:Nitric Oxide / Q000737:chemistry; D019001:Nitric Oxide Synthase / Q000378:metabolism; D009573:Nitrites / Q000378:metabolism; D051381:Rats; D017382:Reactive Oxygen Species; D015398:Signal Transduction; D013045:Species Specificity; D013997:Time Factors; D019323:omega-N-Methylarginine / Q000494:pharmacology
C110400:2',7'-dichlorodihydrofluorescein diacetate; C414689:4,5-diaminofluorescein diacetate; D000941:Antigens; D005452:Fluoresceins; D007202:Indicators and Reagents; D008070:Lipopolysaccharides; D009573:Nitrites; D017382:Reactive Oxygen Species; D019323:omega-N-Methylarginine; D009569:Nitric Oxide; D007073:Immunoglobulin E; D007371:Interferon-gamma; D019001:Nitric Oxide Synthase; D019793:Fluorescein